查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439931

药品合约包装 - 全球市场考量、竞争状况、市场预测 (2030)

Pharmaceutical Contract Packaging - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2022年全球药品合约包装市场规模将达179.6422亿美元，2030年将达289.3235亿美元，2024-2030年预测期内复合年增长率为8.32%。由于日益严格的品质和灭菌要求以及智慧包装解决方案的日益采用，该市场呈现出显着的市场成长。此外，缺乏内部包装能力和专业知识、预算限制、製药公司数量不断增加、全球新药和仿製药上市数量不断增加以及市场上主要参与者的存在等因素正在推动对药品合约包装的需求服务市场，创造需求。因此，预计在 2024 年至 2030 年的预测期内，市场将以显着的复合年增长率成长。

药品合约包装市场动态

药品合约包装市场的关键驱动因素之一是全球对药品的需求不断增长。

例如，印度化学品和化肥部提供的2020-2022年年度报告指出，2020-2022年药品年度总收入为28999.8亿印度卢比。由于全球经济成长、人口老化、患者数量增加以及新产品的推出，全球製药业在世界许多地区呈现巨大的成长。因此，药品需求的增加将增加对药品合约包装的需求，因为企业需要原料和成品（包括药品和设备）的包装服务。此外，许多药品供应商已经意识到，将商业和临床包装外包给药品合约製造商可以增加他们的利润，预计这将在预测期内扩大合约包装市场。

此外，市场上新药和仿製药的增加将增加对许多初级和二级包装（例如瓶子和泡罩）的需求。根据 FDA Center for Drug Evaluation and Research（CDER）的数据，截至 2022 年 10 月，已有 29 种新药获得批准。此外，根据同一数据，2022年将有50个新药获批，2020年将有53个新药获批。此外，2020年仿製药计画核准或临时核准的仿製药申请有948个。因此，FDA批准的新药数量的增加推动了全球药品合约包装市场，因为需要以瓶子、小瓶、泡罩包装等形式包装的新药的推出将增加对包装服务的需求。产生积极影响

此外，主要参与者采取的策略措施同样将推动未来几年对药品合约包装的需求。例如，2020年6月，PCI Pharma宣布与合约製造组织和药品供应服务公司Experic达成合作协议，探索临床和商业製造、包装和供应链服务，推动共同成长。

此外，2022 年 11 月，Carton Service Inc. 的子公司 Pharma Packaging Solutions 被 Tjoapack 收购。Tjoapack 对 PPS 的收购可能会创造一个机会，以发展成为药品合约包装和分销网路服务领域的新的全球领导者。

因此，上述因素将共同推动2022-2028年预测期间的整体药品合约包装市场。

然而，包装成本的增加、监控问题和缺乏标准化可能会阻碍预测期内（2022-2028年）药品合约包装市场的成长。

前所未有的 COVID-19 大流行对药品合约包装市场产生了重大影响。这是因为在疫情爆发初期，由于政府严格的封锁规定，一些行业关闭了生产设施和其他业务。此外，全球封锁和对进出口贸易活动的严格限制导致了病毒的遏制，扰乱了全球供应链并扰乱了药品和医疗器材的製造。相反，随着治疗COVID-19的小瓶和药品等需求的增加，药品合约包装市场呈现快速增长，这导致行业製造商集中资源并加快生产速度，并促进了包装的发展。过程。此外，针对COVID-19的免疫疫苗的需求急剧增加，这增加了对药品合约包装服务的需求。因此，上述因素正在推动药品合约包装市场，预计预测期将保持不变。

本报告提供了全球药品合约包装市场的研究和分析，包括市场规模和预测、驱动因素和挑战、公司和产品概况。

目录

第一章药品合约包装市场报告简介

第二章药品合约包装市场概要

  • 调查范围
  • 市场概况
  • 竞争评估

第三章 监管分析

第四章药品合约包装市场主要因素分析

  • 药品合约包装市场的驱动因素
  • 药品合约包装市场的限制与挑战
  • 药品合约包装市场机遇

第五章药品合约包装市场波特五力分析

第六章 COVID-19对药品合约包装市场的影响分析

第七章 药品合约包装市场布局

  • 按服务类型
    • 初级包装
    • 二次包装
    • 三级包装
  • 按材质
    • 塑胶/聚合物
    • 纸/纸板
    • 玻璃
    • 铝箔
    • 其他
  • 区域
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第八章 药品合约包装市场的公司与产品概况

  • ROPACK INC.
  • Sharp Services, LLC
  • Reed-Lane
  • Unicep
  • PCI Pharma Services
  • Jones Healthcare Group.
  • Almac Group
  • AmeriPac.
  • MJS Packaging
  • Carton Service Inc.
  • Nelipak BV
  • Aphena Pharma Solutions.
  • Tjaopak
  • Central Pharma
  • Wasdell Packaging Group
  • Daklapack Group
  • Experic
  • Amcor plc
  • Tripak Pharmaceuticals
  • CCL Industries Inc.

第9章 KOL观点

第10章项目方法

第 11 章关于 DelveInsight

第十二章 免责声明与联络我们

Product Code: DIMDCL0612

Pharmaceutical Contract Packaging Market By Service Type (Primary Packaging [Bottles, Vials, Ampoules, Blister Packs, And Others], Secondary Packaging, And Tertiary Packaging), By Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing stringent quality requirements specially to the sterilization and lack of in-house packaging capabilities, expertise, and budget constraints

The global pharmaceutical contract packaging market was valued at USD 17,964.22 million in 2022 and is likely to register a CAGR of 8.32% during the forecast period from 2024 to 2030 to reach USD 28,932.35 million by 2030. The pharmaceutical contract packaging market is observing remarkable market growth owing to the factors such as increasingly stringent quality and sterilization requirements and the growing adoption of smart packaging solutions. Further, the lack of in-house packaging capabilities, expertise, and budget constraints, the rising number of pharmaceutical players, the rising launch of new and generic drugs across the globe, the presence of key players in the market, and other factors will create a requisite for the pharmaceutical contract packaging service in the market. Therefore, the market for pharmaceutical contract packaging is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Pharmaceutical Contract Packaging Market Dynamics:

One of the key aspects driving the pharmaceutical contract packaging market is the rising demand for pharmaceutical products globally.

For instance, the annual report for 2020-2022 provided by the Ministry of Chemicals & Fertilizers, India, stated that the total annual turnover of Pharmaceuticals was INR 2,89,998 crore for the year 2020-2022. The global pharmaceutical industry in different regions around the globe is growing exponentially, driven by global economic growth, a growing aging population, a surging patient pool, and new product launches. Thus, the increasing demand for pharmaceutical products will in turn increase the demand for pharmaceutical contract packaging as the companies will be requiring packaging services for their raw materials or end-products (including drugs or devices). Moreover, many pharmaceutical vendors recognized that the profits could be increased by outsourcing the commercial and clinical packaging to a pharmaceutical contractor, thereby expected to expand the contract packaging market during the forecast period.

Further, the increasing number of novel and generic drugs in the market will increase the demand for many primary or secondary packing such as bottles, and blisters, among others. As per the FDA's Center for Drug Evaluation and Research (CDER), till October 2022, nearly 29 novel drugs were approved. Further, as per the same source, 50 novel drugs were approved in 2022 and 53 novel drugs in 2020. Also, the generic drug program approved or tentatively approved 948 generic drug applications during the year 2020. Thus, the increase in the number of new drugs approved by the FDA will positively impact the global pharmaceutical contract packaging market as the launch of new drugs will increase the demand for packing services that require packaging in the form of bottles, vials, blister packs, and others.

Moreover, strategic steps taken by the key players will in turn propel the demand for pharmaceutical contract packing in the upcoming years. For instance, in June 2020, PCI Pharma announced that the company has entered into a partnership agreement with Experic, a contract manufacturing organization, and pharmaceutical supply service company, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Also, in November 2022, Pharma Packaging Solutions, a part of Carton Service Inc., was acquired by Tjoapack. Tjoapack's acquisitions of PPS are likely to lead toward creating opportunities to develop a new worldwide leader in pharmaceutical contractual packaging and distribution network services.

Therefore, the factors stated above collectively will drive the overall pharmaceutical contract packaging market during the forecast period from 2022 - 2028.

However, increased costs of packaging, monitoring issues, and lack of standardization, may hamper the growth of the pharmaceutical contract packaging market during the forecast period (2022 - 2028).

The unprecedented COVID-19 pandemic has had a substantial effect on the pharmaceutical contract packaging market. This is because, in the initial days of the pandemic, several industries had stopped their production units and other operations owing to the imposition of strict lockdown rules by the government. Also, the lockdown across the globe and the stringent regulations on import-export trade activities that had led to the containment of the virus, disrupted the global supply chain, thereby disturbing the manufacturing of the drugs and devices. Contrarily, as the demand for vials, medicines, and other drugs increases to treat the coronavirus infection, the market for pharmaceutical contract packing witnessed a sudden rise, owing to which, the manufacturers in the industry scrambled for their resources and pushed for faster manufacturing and packaging processes. Moreover, the demand for vaccines increased exponentially to immunize people against COVID-19, thereby increasing the demand for pharmaceutical contract packaging services. Henceforth, the afore-said factors were responsible for driving the market of pharmaceutical contract packaging and are anticipated to do the same during the forecast period.

Pharmaceutical Contract Packaging Market Segment Analysis:

Pharmaceutical Contract Packaging Market by Service Type (Primary Packaging [Bottles, Vials, Ampoules, Blister Packs, and Others], Secondary Packaging, and Tertiary Packaging), Material (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the service type segment of the pharmaceutical contract packaging market, the bottles segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the growing requirement for pharmaceutical bottles worldwide and the increasing adoption of pharmaceutical bottles for unit dose packaging.

Also, plastic bottle filling will significantly grow due to its various advantages, including light-weightiness that further saves space and transportation, and freight charges. Plastic bottles are not prone to breakage and help with necessary cost-savings associated with glass bottles.

Additionally, the solid dosages, liquid dosages, and liquid suspensions are filled in glass, metal, and plastic bottles.

Moreover, the increasing demand for injectable pharmaceuticals is significantly driving the growth of glass bottles in the pharmaceutical sector as glass bottles are used to store injectable drugs. Also, the injectable drugs which need to be stored under freezing temperatures are usually stored in glass bottles.

Further, the increasing expansion and funding activities by the key players in bottle packing services will positively influence the growth of the bottle segment in the market. For instance, in January 2022, Aphena Pharma Solutions, an organization providing pharmaceutical contract packaging services, announced that the company had added ten high-speed bottling lines leveraging its USD 21 million investment in solid dosage contract packaging. The company further intends to install 30 more high-speed lines in its newly acquired 500,000 sq. ft. facility to increase the monthly capacity to over 80 million bottles to target the pharmaceutical solid dose packaging industry.

Therefore, owing to the above-mentioned factors, the demand for the bottles rises, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global pharmaceutical contract packaging market during the forecast period.

North America is expected to dominate the overall Pharmaceutical Contract Packaging Market:

Among all the regions, North America is expected to hold the largest share in global pharmaceutical contract packaging in 2022 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the increasing demand for pharmaceutical contract packaging among the region increasing launches of generic or novel drugs, increasing government initiatives concerned with sterilized packaging, technological advancement, the presence of domicile of key players and others will be contributing to the growth of the pharmaceutical contract packaging market in North America.

Further, increasing the adoption of different packaging methods to meet the expectations of changing consumer preferences and rising environmental concerns have stimulated the demand for sustainable contract packaging in the pharmaceutical industry.

Additionally, the rising penetration of automation in pharmaceutical contract packaging has minimized human handling errors and will increase the market growth in the region.

Further, many contract packaging companies have been investing in expanding their presence in the sector through acquisitions and partnerships. For instance, in September 2020, Essentra Packaging announced the purchase of a 3C! Based in North Carolina, Packaging is a designer and manufacturer of cartons, literature, labels, and packaging primarily for the pharmaceutical industry. Such acquisitions allow companies like Essentra Packaging to enhance their position in the pharmaceutical packaging space and provide opportunities to grow in the pharmaceutical manufacturing hub in various regions including North America.

Moreover, the presence of the major market players such as Amcor PLC, Winpak ltd., Sonoco products co., and others will create a positive outlook for the market in North America.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North America region in the pharmaceutical contract packaging market.

Pharmaceutical Contract Packaging Market Key Players:

Some of the key market players operating in the pharmaceutical contract packaging market include ROPACK INC., Sharp Services, LLC, Reed-Lane, Unicep, PCI Pharma Services, Jones Healthcare Group., Almac Group, AmeriPac., MJS Packaging, Carton Service Inc., Nelipak BV, Aphena Pharma Solutions., Tjaopak, Central Pharma, Wasdell Packaging Group, Daklapack Group, Experic, Amcor plc, Tripak Pharmaceuticals, CCL Industries Inc., and others.

Recent Developmental Activities in the Pharmaceutical Contract Packaging Market:

In April 2022, Catalent completed a USD 14 million expansion for increasing biologics packaging capabilities and capacity at its Bloomington, Indiana facility.

In May 2022, Sharp, a contract packaging, clinical supply services company owned by UDG Healthcare plc, purchased new land as part of a USD 17 million investment in its Conshohocken, PA location. This land purchase will enable Sharp to add future capacity for cGMP packaging services and is part of a broader USD 43 million investment into its Pennsylvania operations, increasing the firm's blister packaging capacity by over 35%.

In September 2020, Legacy Pharmaceutical Packaging expanded its services, including 3PL services, covering supply chain transparency solutions and retail pharma product procurement for over-the-counter medications. In addition to this, the company also expanded its open-space facility near its St Louis, MO, headquarters from 215,000 ft2 to 500,000 ft2.

Key Takeaways from the Pharmaceutical Contract Packaging Market Report Study

  • Market size analysis for current pharmaceutical contract packaging market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the pharmaceutical contract packaging market.
  • Top key products/services/developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global pharmaceutical contract packaging market.
  • Various opportunities available for the other competitor in the pharmaceutical contract packaging market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current pharmaceutical contract packaging market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for pharmaceutical contract packaging market growth in the coming future?

Target Audience who can be benefited from this Pharmaceutical Contract Packaging Market Report Study

  • Pharmaceutical contract packaging providers
  • Research organizations and consulting companies
  • Pharmaceutical contract packaging -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in pharmaceutical contract packaging
  • Various end users who want to know more about the pharmaceutical contract packaging market and the latest developments in the pharmaceutical contract packaging market.

Frequently Asked Questions for the Pharmaceutical Contract Packaging Market:

1. What is pharmaceutical contract packaging?

Pharmaceutical contract packaging is a type of service in which the company provides all the packaging functions from the simplest to the most complex and from the glamorous to the hazardous.

2. What is the global market for pharmaceutical contract packaging?

The global pharmaceutical contract packaging market was valued at USD 17,964.22 million in 2022 and is likely to register a CAGR of 8.32% during the forecast period from 2024 to 2030 to reach USD 28,932.35 million by 2030.

3. What are the drivers for the global pharmaceutical contract packaging market?

The pharmaceutical contract packaging market is witnessing positive market growth owing to the factors such as the increasingly stringent quality requirements, the rising number of pharmaceutical players across the globe, and the rising efforts towards sterilization of the end products. Further, the lack of in-house packaging capabilities, expertise, and budget constraints among small-scale companies will create an exigency for the pharmaceutical contract packaging market.

4. Who are the key players operating in the global pharmaceutical contract packaging market?

Some of the key market players operating in the pharmaceutical contract packaging market include ROPACK INC., Sharp Services, LLC, Reed-Lane, Unicep, PCI Pharma Services, Jones Healthcare Group., Almac Group, AmeriPac., MJS Packaging, Carton Service Inc., Nelipak BV, Aphena Pharma Solutions., Tjaopak, Central Pharma, Wasdell Packaging Group, Daklapack Group, Experic, Amcor plc, Tripak Pharmaceuticals, CCL Industries Inc., and others.

5. Which region has the highest share of the pharmaceutical contract packaging market?

Among all the regions, North America is estimated to hold the major revenue share in the global pharmaceutical contract packaging market. This can be ascribed to the increasing launches of generic or novel drugs, increasing government initiatives concerned with sterilized packaging, technological advancement, and the presence of key players in the region are the reasons which act as a supportive factor for the North America pharmaceutical contract packaging market growth.

Table of Contents

1.Pharmaceutical Contract Packaging Market Report Introduction

2. Pharmaceutical Contract Packaging Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

4. Pharmaceutical Contract Packaging Market Key Factors Analysis

  • 4.1. Pharmaceutical Contract Packaging Market Drivers
    • 4.1.1. Increasing stringent quality requirements
    • 4.1.2. Lack of in-house packaging capabilities, expertise, and budget constraints
    • 4.1.3. The rising number of pharmaceutical industries across the globe
    • 4.1.4. Growing adoption of smart packaging solutions
  • 4.2. Pharmaceutical Contract Packaging Market Restraints and Challenges
    • 4.2.1. Increased costs of packaging
    • 4.2.2. Monitoring issues and lack of standardization
  • 4.3. Pharmaceutical Contract Packaging Market Opportunities
    • 4.3.1. Rising outsourcing of pharmaceutical packaging to contract packagers in emerging countries
    • 4.3.2. Rising capacity expansions & investments in expanding bottling and filling services

5. Pharmaceutical Contract Packaging Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market

7. Pharmaceutical Contract Packaging Market Layout

  • 7.1. By Service Type
    • 7.1.1. Primary Packaging
      • 7.1.1.1. Bottles
      • 7.1.1.2. Vials
      • 7.1.1.3. Ampoules
      • 7.1.1.4. Blister Packs
      • 7.1.1.5. Others
    • 7.1.2. Secondary Packaging
    • 7.1.3. Tertiary Packaging
  • 7.2. By Material
    • 7.2.1. Plastics & Polymers
    • 7.2.2. Paper & Paperboard
    • 7.2.3. Glass
    • 7.2.4. Aluminum Foil
    • 7.2.5. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.1.2. Canada Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.1.3. Mexico Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.2. Germany Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.4. Italy Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.5. Spain Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.2. Japan Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.3. India Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.4. Australia Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.5. South Korea Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia Pacific Pharmaceutical Contract Packaging Market in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.4.2. Africa Pharmaceutical Contract Packaging Market in USD million (2021-2030)
      • 7.3.4.3. South America Pharmaceutical Contract Packaging Market in USD million (2021-2030)

8. Pharmaceutical Contract Packaging Market Company and Product Profiles

  • 8.1. ROPACK INC.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Sharp Services, LLC
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Reed-Lane
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Unicep
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. PCI Pharma Services
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Jones Healthcare Group.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Almac Group
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. AmeriPac.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. MJS Packaging
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Carton Service Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Nelipak BV
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Aphena Pharma Solutions.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Tjaopak
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Central Pharma
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Wasdell Packaging Group
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Daklapack Group
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Experic,
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Amcor plc
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Tripak Pharmaceuticals
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. CCL Industries Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market
  • Table 3: Pharmaceutical Contract Packaging Market Analysis in Global (2021-2030)
  • Table 4: Pharmaceutical Contract Packaging Market Analysis in Global by Service Type (2021-2030)
  • Table 5: Pharmaceutical Contract Packaging Market Analysis in Global by Material (2021-2030)
  • Table 6: Pharmaceutical Contract Packaging Market Analysis in Global by Geography (2021-2030)
  • Table 7: Pharmaceutical Contract Packaging Market Analysis in North America (2021-2030)
  • Table 8: Pharmaceutical Contract Packaging Market Analysis in North America by Country (2021-2030)
  • Table 9: Pharmaceutical Contract Packaging Market Analysis in the US (2021-2030)
  • Table 10: Pharmaceutical Contract Packaging Market Analysis in Canada (2021-2030)
  • Table 11: Pharmaceutical Contract Packaging Market Analysis in Mexico (2021-2030)
  • Table 12: Pharmaceutical Contract Packaging Market Analysis in Europe (2021-2030)
  • Table 13: Pharmaceutical Contract Packaging Market Analysis in Europe by Country (2021-2030)
  • Table 14: Pharmaceutical Contract Packaging Market Analysis in France (2021-2030)
  • Table 15: Pharmaceutical Contract Packaging Market Analysis in Germany (2021-2030)
  • Table 16: Pharmaceutical Contract Packaging Market Analysis in the UK (2021-2030)
  • Table 17: Pharmaceutical Contract Packaging Market Analysis in Italy (2021-2030)
  • Table 18: Pharmaceutical Contract Packaging Market Analysis in Spain (2021-2030)
  • Table 19: Pharmaceutical Contract Packaging Market Analysis in the Rest of Europe (2021-2030)
  • Table 20: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific (2021-2030)
  • Table 21: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 22: Pharmaceutical Contract Packaging Market Analysis in China (2021-2030)
  • Table 23: Pharmaceutical Contract Packaging Market Analysis in Japan (2021-2030)
  • Table 24: Pharmaceutical Contract Packaging Market Analysis in India (2021-2030)
  • Table 25: Pharmaceutical Contract Packaging Market Analysis in Australia (2021-2030)
  • Table 26: Pharmaceutical Contract Packaging Market Analysis in South Korea (2021-2030)
  • Table 27: Pharmaceutical Contract Packaging Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Table 28: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World (2021-2030)
  • Table 29: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World by Region (2021-2030)
  • Table 30: Pharmaceutical Contract Packaging Market Analysis in the Middle East (2021-2030)
  • Table 31: Pharmaceutical Contract Packaging Market Analysis in Africa (2021-2030)
  • Table 32: Pharmaceutical Contract Packaging Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis on Pharmaceutical Contract Packaging Market
  • Figure 3: Pharmaceutical Contract Packaging Market Analysis in Global (2021-2030)
  • Figure 4: Pharmaceutical Contract Packaging Market Analysis in Global by Service Type (2021-2030)
  • Figure 5: Pharmaceutical Contract Packaging Market Analysis in Global by Material (2021-2030)
  • Figure 6: Pharmaceutical Contract Packaging Market Analysis in Global by Geography (2021-2030)
  • Figure 7: Pharmaceutical Contract Packaging Market Analysis in North America (2021-2030)
  • Figure 8: Pharmaceutical Contract Packaging Market Analysis in North America by Country (2021-2030)
  • Figure 9: Pharmaceutical Contract Packaging Market Analysis in the US (2021-2030)
  • Figure 10: Pharmaceutical Contract Packaging Market Analysis in Canada (2021-2030)
  • Figure 11: Pharmaceutical Contract Packaging Market Analysis in Mexico (2021-2030)
  • Figure 12: Pharmaceutical Contract Packaging Market Analysis in Europe (2021-2030)
  • Figure 13: Pharmaceutical Contract Packaging Market Analysis in Europe by Country (2021-2030)
  • Figure 14: Pharmaceutical Contract Packaging Market Analysis in France (2021-2030)
  • Figure 15: Pharmaceutical Contract Packaging Market Analysis in Germany (2021-2030)
  • Figure 16: Pharmaceutical Contract Packaging Market Analysis in the UK (2021-2030)
  • Figure 17: Pharmaceutical Contract Packaging Market Analysis in Italy (2021-2030)
  • Figure 18: Pharmaceutical Contract Packaging Market Analysis in Spain (2021-2030)
  • Figure 19: Pharmaceutical Contract Packaging Market Analysis in the Rest of Europe (2021-2030)
  • Figure 20: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific (2021-2030)
  • Figure 21: Pharmaceutical Contract Packaging Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 22: Pharmaceutical Contract Packaging Market Analysis in China (2021-2030)
  • Figure 23: Pharmaceutical Contract Packaging Market Analysis in Japan (2021-2030)
  • Figure 24: Pharmaceutical Contract Packaging Market Analysis in India (2021-2030)
  • Figure 25: Pharmaceutical Contract Packaging Market Analysis in Australia (2021-2030)
  • Figure 26: Pharmaceutical Contract Packaging Market Analysis in South Korea (2021-2030)
  • Figure 27: Pharmaceutical Contract Packaging Market Analysis in the Rest of Asia-Pacific (2021-2030)
  • Figure 28: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World (2021-2030)
  • Figure 29: Pharmaceutical Contract Packaging Market Analysis in the Rest of the World by Region (2021-2030)
  • Figure 30: Pharmaceutical Contract Packaging Market Analysis in the Middle East (2021-2030)
  • Figure 31: Pharmaceutical Contract Packaging Market Analysis in Africa (2021-2030)
  • Figure 32: Pharmaceutical Contract Packaging Market Analysis in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Market Opportunities
  • Figure 36: PORTER's Five Force Analysis